| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.42 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |